Journal of the American Society of Nephrology, Vol 7, 2025-2043, Copyright © 1996 by American Society of Nephrology

REVIEWS

Angiotensin in progressive renal diseases: theory and practice

T Matsusaka, J Hymes and I Ichikawa

Experimental studies indicate that Angll is involved in the process of tissue destruction in chronic renal diseases. This notion has been verified in a number of small-to large-scale clinical studies using angiotensin (ANG) I converting enzyme inhibitors (ACEI). Although the repertoire of the pathophysiologic cascade underlying the progressive destruction of renal tissue has continued to expand over recent years, from proteinuria and physical forces to growth factors and metalloproteinase disregulations, studies now suggest that Angll is involved in many, if not all, of these processes. Because these expanded pathophysiologic potentials of Angll are based primarily on observations in vitro, their significance in vivo, and in humans in particular, needs to be established. Recent studies in animals and humans indicate that the role of Angll in renal tissue destruction is subject to the modulation of multiple environmental and genetic factors, such as dietary habit and ACE genotype. Further delineation of the role of Angll in this respect for specific renal diseases and patients will enable us to design an efficient therapeutic intervention for this otherwise most complex problem of today's nephrology.

This article has been cited by other articles:

				P. Vieitez, O. Gomez, E. R Uceda, M. E. Vera, and E. Molina-Holgado Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 96 - 102. [Abstract] [PDF]

				Z.-G. Xu, H. Yuan, L. Lanting, S.-L. Li, M. Wang, N. Shanmugam, M. Kato, S. G. Adler, M. A. Reddy, and R. Natarajan Products of 12/15-Lipoxygenase Upregulate the Angiotensin II Receptor J. Am. Soc. Nephrol., March 1, 2008; 19(3): 559 - 569. [Abstract] [Full Text] [PDF]

				Y. Takeuchi, K. Yamauchi, J. Nakamura, S. Shigematsu, and K. Hashizume Angiotensin II regulates migration in mouse cultured mesangial cells: evidence for the presence of receptor subtype-specific regulation. J. Endocrinol., November 1, 2006; 191(2): 361 - 367. [Abstract] [Full Text] [PDF]

				J. L. Faulkner, L. M. Szcykalski, F. Springer, and J. L. Barnes Origin of Interstitial Fibroblasts in an Accelerated Model of Angiotensin II-Induced Renal Fibrosis Am. J. Pathol., November 1, 2005; 167(5): 1193 - 1205. [Abstract] [Full Text] [PDF]

				Y. Tabel, A. Berdeli, S. Mir, E. Serdaroglu, and E. Ytlmaz Effects of Genetic Polymorphisms of the Renin-Angiotensin System in Children with Nephrotic Syndrome Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 138 - 144. [Abstract] [PDF]

				Y. Nagashio, H. Asaumi, S. Watanabe, Y. Nomiyama, M. Taguchi, M. Tashiro, T. Sugaya, and M. Otsuki Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G170 - G177. [Abstract] [Full Text] [PDF]

				J. Ma, T. Matsusaka, H. Yang, H. Kawachi, F. Shimizu, Y. Isaka, E. Imai, V. Kon, and I. Ichikawa Local Actions of Endogenous Angiotensin II in Injured Glomeruli J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1268 - 1276. [Abstract] [Full Text] [PDF]

				H.L. Hillege, W.H. van Gilst, D.J. van Veldhuisen, G. Navis, D.E. Grobbee, P.A. de Graeff, and D. de Zeeuw Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial Eur. Heart J., March 1, 2003; 24(5): 412 - 420. [Abstract] [Full Text] [PDF]

				G. Ding, K. Reddy, A. A. Kapasi, N. Franki, N. Gibbons, B. S. Kasinath, and P. C. Singhal Angiotensin II induces apoptosis in rat glomerular epithelial cells Am J Physiol Renal Physiol, July 1, 2002; 283(1): F173 - F180. [Abstract] [Full Text] [PDF]

				Y. Xia, H. Y. Wen, and R. E. Kellems Angiotensin II Inhibits Human Trophoblast Invasion through AT1 Receptor Activation J. Biol. Chem., June 28, 2002; 277(27): 24601 - 24608. [Abstract] [Full Text] [PDF]

				Y.-J. Lee and J. C.R. Tsai ACE Gene Insertion/Deletion Polymorphism Associated With 1998 World Health Organization Definition of Metabolic Syndrome in Chinese Type 2 Diabetic Patients Diabetes Care, June 1, 2002; 25(6): 1002 - 1008. [Abstract] [Full Text] [PDF]

				L. R. James, A. Ingram, H. Ly, K. Thai, L. Cai, and J. W. Scholey Angiotensin II activates the GFAT promoter in mesangial cells Am J Physiol Renal Physiol, July 1, 2001; 281(1): F151 - F162. [Abstract] [Full Text] [PDF]

				S. Adler, H. Huang, K. E. Loke, X. Xu, H. Tada, A. Laumas, and T. H. Hintze Endothelial nitric oxide synthase plays an essential role in regulation of renal oxygen consumption by NO Am J Physiol Renal Physiol, May 1, 2001; 280(5): F838 - F843. [Abstract] [Full Text] [PDF]

				K. A Griffin, M. M Picken, G. Bakris, and A. K Bidani Relative antihypertensive and glomeruloprotective efficacies of enalapril and candesartan cilexetil in the remnant kidney model Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S191 - S195. [Abstract] [PDF]

				M. SATOH, N. KASHIHARA, Y. YAMASAKI, K. MARUYAMA, K. OKAMOTO, Y. MAESHIMA, H. SUGIYAMA, T. SUGAYA, K. MURAKAMI, and H. MAKINO Renal Interstitial Fibrosis Is Reduced in Angiotensin II Type 1a Receptor-Deficient Mice J. Am. Soc. Nephrol., February 1, 2001; 12(2): 317 - 325. [Abstract] [Full Text]

				E. P. Cohen, S. A. Bonsib, E. Whitehouse, J. W. Hopewell, and M. E. C. Robbins Mediators and Mechanisms of Radiation Nephropathy Experimental Biology and Medicine, February 1, 2000; 223(2): 218 - 225. [Abstract] [Full Text]

				J. Redon, F. J. Chaves, Y. Liao, J. M. Pascual, E. Rovira, M. E. Armengod, and R. S. Cooper Influence of the I/D Polymorphism of the Angiotensin-Converting Enzyme Gene on the Outcome of Microalbuminuria in Essential Hypertension Hypertension, January 1, 2000; 35(1): 490 - 495. [Abstract] [Full Text] [PDF]

				J. C. Romero and J. F. Reckelhoff Role of Angiotensin and Oxidative Stress in Essential Hypertension Hypertension, October 1, 1999; 34(4): 943 - 949. [Abstract] [Full Text] [PDF]

				R. Largo, D. Gomez-Garre, K. Soto, B. Marron, J. Blanco, R. M. Gazapo, J. J. Plaza, and J. Egido Angiotensin-Converting Enzyme Is Upregulated in the Proximal Tubules of Rats With Intense Proteinuria Hypertension, February 1, 1999; 33(2): 732 - 739. [Abstract] [Full Text] [PDF]

				G. Remuzzi and T. Bertani Pathophysiology of Progressive Nephropathies N. Engl. J. Med., November 12, 1998; 339(20): 1448 - 1456. [Full Text] [PDF]

				W. A. Border and N. A. Noble Interactions of Transforming Growth Factor-{beta} and Angiotensin II in Renal Fibrosis Hypertension, January 1, 1998; 31(1): 181 - 188. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673